��������

Stelia Ntika, PhD, is an accomplished scientist specializing in analytical development and quality control GMP at Procella Therapeutics AB since August 2022, where instrumental support contributed to the successful GLP-tox campaign. Stelia co-founded hejfin in April 2022, an app aimed at financial education for women and non-binary individuals, and participated in the KTH pre-incubator program. Previous experience includes an internship at the Swedish Institute for Standards, focusing on medical device testing methods, and involvement in clinical research at Södertälje Sjukhus AB and DEMO Pharmaceuticals S.A. Stelia obtained a PhD from Karolinska Institutet, with a thesis on GLP-1 secretion in relation to thoracic aortic aneurysms, and holds a Master's degree in Neurochemistry from Stockholm University, as well as a Bachelor's degree in Chemistry from the National & Kapodistrian University of Athens.